Novo estimates 1.5 million use weight loss drug copies

In the USA, up to 1.5 million patients are using copy versions of popular weight loss drugs, including Novo Nordisk’s Wegovy, due to shortage and high demand. Compounders, who produce these copies, have capitalized on price-sensitive customers. Novo Nordisk is reevaluating its pricing and accessibility strategy for weight loss medications based on this situation. Despite […]